You are here

Home

Grannus Therapeutics, Inc.

Company Information
Address
7210 N Pennsylvania St
Indianapolis, IN 46240-3038
United States
Information

UEI: CKYDPT5R18Z8

# of Employees: 2
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 2

  1. New Treatments for Glaucoma

    Amount: $346,562.00

    Abstract Aggregation of mutated myocilin (MYOC), a protein found in the endoplasmic reticulum (ER) of trabecular meshwork (TM) cells, disrupts the outflow of aqueous humor from the eye, causing increa ...

    STTRPhase I2021Department of Health and Human Services National Institutes of Health

  2. Development of Hsp90 beta-selective inhibitors as safer anti-cancer agents

    Amount: $233,195.00

    Abstract The 90 kD heat shock proteins (Hsp90) are molecular chaperones that are responsible for the folding of select proteins, many of which are directly associated with cancer progression. Conseque ...

    STTRPhase I2020Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government